•
Jun 30, 2023

AST SpaceMobile Q2 2023 Earnings Report

Confirmed space-based 4G LTE cellular broadband capabilities and completed interim financing package.

Key Takeaways

AST SpaceMobile achieved space-based 4G LTE cellular broadband capabilities to everyday smartphones, reaching speeds above 10 Mbps during BlueWalker 3 testing. They completed a comprehensive financing package providing up to $179 million of cash and liquidity.

Confirmed space-based 4G LTE cellular broadband capabilities to everyday smartphones, reaching speeds above 10 Mbps during BlueWalker 3 testing.

Continued commercial and regulatory progress, with 40+ MOUs and agreements with mobile network operators globally that have ~2.4 billion subscribers.

Block 1 BlueBird program is fully-funded, with manufacturing underway and ramping ahead of the planned launch in Q1 2024 of our first five commercial satellites.

Raised cash and liquidity of up to $179 million, with a comprehensive financing package of non-dilutive debt and equity designed to support strategic investment process.

Total Revenue
$0
Previous year: $7.26M
-100.0%
EPS
-$0.24
Previous year: -$0.06
+300.0%
Cash and Equivalents
$191M
Previous year: $202M
-5.7%
Total Assets
$408M
Previous year: $385M
+6.1%

AST SpaceMobile

AST SpaceMobile

Forward Guidance

AST SpaceMobile is focused on manufacturing BlueBird satellites and plans to offer initial commercial service in 2024.

Positive Outlook

  • First five satellites are fully-funded with a planned launch in Q1 2024.
  • Targeting to offer initial commercial service in 2024.
  • Received multiple indications of interest for strategic investments.
  • Strategic investments include both equity-linked and non-dilutive commercial payments.
  • Prospective capital raise are intended to fund the manufacturing and launch of additional BlueBird satellites launches beyond our first five commercial satellites.

Challenges Ahead

  • Ongoing testing of the BW3 satellite may not be completed due to a variety of factors.
  • BW3 testing may indicate adjustments that are needed or modifications that must be made.
  • Delays or issues with additional testing, it may become more costly to raise capital
  • Ability to finance its research and development activities.
  • Commercial partnership acquisition and retention.